Latest Posts


May 24

Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development

Frankfurt, Germany, 3rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled...
Read More


Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More
Try Ontosight® For Free

Blockchain in Healthcare: 6 Possible Use Cases

According to one study, the United States healthcare system ranked last among 11 industrialized nations in terms of access, equity, quality, efficiency, and healthy lives. And it’s not as if there was foreign bias skewing the results — the Commonwealth Fund, which published the study, is a U.S.-based foundation aiming to improve the overall state of healthcare through objective analysis. Their analysis found that the United States spent $8,508 per person on healthcare in 2011, compared with $3,406 in the United Kingdom, which ranked first overall. Other findings suggest that hospitals could increase care output by as much as 26% if they were to find new ways to eliminate inefficiency in their operations. The blockchain may serve as the means to realize greater outputs, especially if hospitals are able to employ it in a comprehensive manner, from improving time-consuming electronic health records systems to rooting out fraud and exploring other ways that the technology can help strengthen the standing of the American healthcare system.

Reducing Counterfeit Pharmaceuticals

Drug counterfeiting takes a staggering toll on global health and the cost of pharmaceuticals. The World Health Organization estimates that worldwide, 10% of pharmaceutical drugs are counterfeit. This amounts to $75 billion annually going to illegal drug manufacturers, who are responsible for an estimated 100,000 deaths due to the drugs being either unsafe, ineffective, or both. However, this is a particularly difficult market to police, as 40% of pharmaceutical drugs are manufactured overseas, and approximately 80% of the active medicinal components of drugs are imported.

These figures illustrate why the blockchain is so needed as a record to unify drug suppliers, with the decentralized technology taking the place of what have proven to be dangerously centralized databases. The blockchain record would provide greater accountability of supply chain members and allow authorities to identify and root out fraudulent batches more rapidly. See the section on supply chain to understand how blockchains can improve provenance of goods like pharmaceuticals.

Companies Trying to Solve This Problem

  • Blockverify –Better tracking of drugs, increased transparency
  • Innoplexus – Improving drug provenance on the blockchain

Clinical Trials


Risk aversion in medical testing and research has led to an industry standard of near 100% source data verification, which is a measure to ensure that no fraudulent data exists in any aspect of a study. This is costly, with studies finding that more than one-third of a Phase 3 trial budget is typically consumed by source data verification processes. In medical device clinical trials, 15% of the overall budget is typically dedicated to SDV monitoring processes, with little return on investment. The $150,000 spent on SDV in a million dollar trial has been found to produce a return on investment of $525.

By utilizing the blockchain’s cryptographic hashing systems, which verify and timestamp data, these costs could be drastically reduced. By hashing and storing each element of a clinical trial as the proceedings occur, the current post-study verification processes — which is riddled with costly redundancy — will become a tragic figment of the past.

Companies Trying to Solve This Problem

  • Innoplexus – Improving drug provenance on the blockchain

You can read the full article here: disruptordaily.

Featured News

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce…